Common Shares

The reporting person redeemed 2,000 common units of limited partnership interest ("Common Units") of COPT Defense Properties, L.P., of which the issuer is the general partner. Common Units are convertible into an equal number of the issuer's common shares of beneficial interest or, at the election of the issuer, cash equal to the fair market value of such shares. In the case of these 2,000 Common Units, the issuer elected to pay cash upon the conversion of the reporting person's Common Units, based on the 10-day average closing price of the issuer's common shares on the New York Stock Exchange. Common Units have no expiration date.

Common Units are convertible upon issuance.


Common Stock, par value $0.001 per share

Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund.

Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account.

Opaleye Management Inc. disclaims beneficial ownership of the shares reported herein except to the extent of its pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that Opaleye Management Inc. is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Opaleye Management Inc., By: /s/ James Silverman, President


Represents shares of Common Stock that the reporting person forfeited to the Company to satisfy tax withholding obligations incurred upon the vesting of restricted stock units. No shares were sold by the reporting person.


Non-qualified Stock Option (Right to Buy)

Common Stock

As indicated by the checkbox above, this transaction was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 9, 2025.

Shares held in the reporting person's name or in the Marc R. Benioff Revocable Trust.

Weighted average price.  These shares were sold in multiple transactions at prices ranging from $250.3500 to $251.3269 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Weighted average price.  These shares were sold in multiple transactions at prices ranging from $251.3919 to $252.3900 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Weighted average price.  These shares were sold in multiple transactions at prices ranging from $252.4000 to $253.3837 inclusive.  The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Weighted average price.  These shares were sold in multiple transactions at prices ranging from $253.4857 to $254.1315 inclusive.  The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Weighted average price.  These shares were sold in multiple transactions at prices ranging from $254.5800 to $254.9900 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Shares held in the Marc Benioff Fund LLC (the "Fund").  Fund interests are held in the reporting person's name or in trust.

Option vests over four years at the rate of 25% on March 22, 2020, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.

/s/ Andrew Leeds, Attorney-in-Fact for Marc Benioff


Ryan Christopher Michael

C/O GEVO, INC. 345 INVERNESS DRIVE SOUTH

Represents shares sold by the Reporting Person to cover tax withholding obligations upon vesting of a restricted stock award. The reported sales were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.23 to $1.29 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Between June 9, 2025 and August 1, 2025, the reporting person disposed of 17 shares of the issuer's common stock under the issuer's 401(k) plan to cover administrative fees. The information in this report is based on a plan statement dated July 25, 2025.


Common Stock

Common Stock

Shares acquired upon the vesting of May 1, 2024 and November 1, 2024 awards of service-based Restricted Stock Units.

Each Restricted Stock Unit represents a contingent right to receive one share of F5, Inc. Common Stock on the vest date.

This May 1, 2024 award of service-based Restricted Stock Units vests 25% on May 1, 2025, with the remaining balance vesting in twelve equal quarterly increments beginning August 1, 2025 until the award is fully vested on May 1,2028.

If the reporting person continues to provide services to the Company through the vest date, the corresponding number of shares of Common Stock of F5, Inc. will be issued to the reporting person on the vest date.

The service-based Restricted Stock Units (RSUs) outstanding under this November 1, 2024 grant vest as follows: 113 vest August 1, 2025, 114 vest November 1, 2025, 113 vest February 1, 2026, 113 vest May 1, 2026, 113 vest August 1, 2026, and 114 vest November 1, 2026.

/s/ Joseph P. McDermott by Power of Attorney


Non-Qualified Stock Option (right to buy)

Common Stock

Adoption date of referenced 10b5-1(c) plan is: 02-22-2024

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.87 to $17.36 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This time based Stock Option Grant vested as to 1/4 on 8/31/2020 and 1/16 each quarter thereafter.

/s/ Katayoun "Katy" Motiey, Power of Attorney for Ed Meyercord


Represents shares sold by the Reporting Person to cover tax withholding obligations upon vesting of a restricted stock award. The reported sales were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 14, 2024.

Between June 9, 2025 and August 1, 2025, the reporting person disposed of 17.44 shares of the issuer's common stock under the issuer's 401(k) plan to cover administrative fees. The information in this report is based on a plan statement dated July 25, 2025.


Common Stock

The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 10, 2025.

This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $10.4800 to $10.4850. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions.

The June 12, 2019, stock option grant vested in substantially equal annual installments over five years starting March 28, 2020, until fully vested on March 28, 2024.

Approximately 35% represents time-based options which vested in substantially equal annual installments over five years starting March 28, 2020, and approximately 65% represents performance-based options, of which 25% vested upon the initial public offering and the remainder will be eligible for vesting upon satisfaction of certain performance criteria including stock price performance.


Common Stock

Common Stock

Common Stock

Represents dividend equivalent rights accrued on existing time-based restricted stock units, the grant of which was previously reported, in connection with the issuer's quarterly dividend. Such dividend equivalent units will vest on the same schedule and are subject to the same terms and conditions as the underlying awards.

Includes 193,796 unvested restricted stock units.

Class B Profits Units of Rithm Capital Management LLC ("RCM") will be exchangeable into shares of Common Stock of the Issuer on a one-for-one basis pursuant to the terms and conditions set forth in the Rithm Capital Management LLC Long Term Incentive Plan and the individual award agreement.

Represents dividend equivalent rights accrued on existing Class B Profits Units, the grant of which was previously reported, in connection with the Issuer's quarterly dividend. Such dividend equivalent Class B Profits Units will vest on the same schedule and are subject to the same terms and conditions as the underlying awards.

Reflects a profits interest award in the form of Class B Profits Units in RCM granted to the Reporting Person on March 15, 2024, which will vest in three equal annual installments on March 15 of each of 2025, 2026 and 2027, so long as the Reporting Person remains in continued employment with the Issuer. These Class B Profits Units will be exchangeable into shares of Common Stock of the Issuer on a one-for-one basis after they have become vested and a sufficient amount of profits have been allocated to the holder of the Class B Profits Units.

Reflects a profits interest award in the form of Class B Profits Units in RCM earned based on annual return on equity for the 2024 performance period. As of January 27, 2025, performance-based criteria have been satisfied for 1 of the 3 tranches, which will vest on March 15, 2027, so long as the Reporting Person remains in continued employment with the Issuer. These Class B Profits Units are exchangeable into shares of Common Stock of the Issuer on a one-for-one basis after they have become vested and a sufficient amount of profits have been allocated to the holder of the Class B Profits Units.

Reflects a profits interest award in the form of Class B Profits Units in RCM granted to the Reporting Person on February 24, 2025, which will vest in three equal annual installments on February 24 of each of 2026, 2027 and 2028, so long as the Reporting Person remains in continued employment with the Issuer. These Class B Profits Units will be exchangeable into shares of Common Stock of the Issuer on a one-for-one basis after they have become vested and a sufficient amount of profits have been allocated to the holder of the Class B Profits Units.

/s/ Nicola Santoro Jr., as attorney-in-fact for Michael Nierenberg


Common Stock

Common Stock

Common Stock

Shares acquired upon the vesting of November 1, 2022, November 1, 2023, and November 1, 2024 awards of service-based Restricted Stock Units.

This transaction was executed pursuant to a Rule 10b5-1 trading plan dated 11/13/2024.

These shares are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the trust.

Each Restricted Stock Unit represents a contingent right to receive one share of F5, Inc. Common Stock on the vest date.

This November 1, 2022 award of service-based Restricted Stock Units vests in twelve equal quarterly increments beginning February 1, 2023.

If the reporting person continues to provide services to the Company through the vest date, the corresponding number of shares of Common Stock of F5, Inc. will be issued to the reporting person on the vest date.

This November 1, 2023 award of service-based Restricted Stock Units vests in twelve equal quarterly increments beginning February 1, 2024.

This November 1, 2024 award of service-based Restricted Stock Units vests in twelve equal quarterly increments beginning  February 1, 2025.


Shares of common stock issued in lieu of $35,000 quarterly cash retainer per the terms of the Registrant's Non-Employee Director Compensation Program.

Annual grant of restricted stock units received for no consideration and vests 100% on the first anniversary of the date of grant.

/s/ Elizabeth S. Campbell, attorney-in-fact for Dennis M. Nally


This transaction represents an exchange of Class A Common Stock for Common Stock.


ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/

Bona fide gift


Common Stock

Common Stock

Common Stock

Represents dividend equivalent rights accrued on existing time-based restricted stock units, the grant of which was previously reported, in connection with the issuer's quarterly dividend. Such dividend equivalent units will vest on the same schedule and are subject to the same terms and conditions as the underlying awards.

Includes 27,683 unvested restricted stock units.

Class B Profits Units of Rithm Capital Management LLC ("RCM") will be exchangeable into shares of Common Stock of the Issuer on a one-for-one basis pursuant to the terms and conditions set forth in the Rithm Capital Management LLC Long Term Incentive Plan and the individual award agreement.

Represents dividend equivalent rights accrued on existing Class B Profits Units, the grant of which was previously reported, in connection with the Issuer's quarterly dividend. Such dividend equivalent Class B Profits Units will vest on the same schedule and are subject to the same terms and conditions as the underlying awards.

Reflects a profits interest award in the form of Class B Profits Units in RCM granted to the Reporting Person on February 23, 2024, which will vest in three equal annual installments on February 23 of each of 2025, 2026 and 2027, so long as the Reporting Person remains in continued employment with the Issuer. These Class B Profits Units will be exchangeable into shares of Common Stock of the Issuer on a one-for-one basis after they have become vested and a sufficient amount of profits have been allocated to the holder of the Class B Profits Units.

Reflects a profits interest award in the form of Class B Profits Units in RCM earned based on annual return on equity for the 2024 performance period. As of January 27, 2025, performance-based criteria have been satisfied for 1 of the 3 tranches, which will vest on February 23, 2027, so long as the Reporting Person remains in continued employment with the Issuer. These Class B Profits Units are exchangeable into shares of Common Stock of the Issuer on a one-for-one basis after they have become vested and a sufficient amount of profits have been allocated to the holder of the Class B Profits Units.

Reflects a profits interest award in the form of Class B Profits Units in RCM granted to the Reporting Person on February 24, 2025, which will vest in three equal annual installments on February 24 of each of 2026, 2027 and 2028, so long as the Reporting Person remains in continued employment with the Issuer. These Class B Profits Units will be exchangeable into shares of Common Stock of the Issuer on a one-for-one basis after they have become vested and a sufficient amount of profits have been allocated to the holder of the Class B Profits Units.


Common Stock

Restricted stock units convert into common stock on a one-for-one basis.

One-third of these restricted stock units will vest on each anniversary of the grant date, August 1, 2025.


Shares withheld by the Company to satisfy tax withholding obligations upon vesting of RSUs; not an open market transaction.

Includes shares acquired pursuant to NIKE, Inc.'s Employee Stock Purchase Plan.

/s/ Kelsey A. Baldwin, attorney-in-fact for Mr. Friend


Common Stock

Common Stock

Reflects a profits interest award in the form of Class B Profits Units in RCM granted to the Reporting Person on  May 1, 2024, which will vest in two equal installments on January 1 of each of 2025 and 2026, so long as the Reporting Person remains in continued employment with the Issuer. These Class B Profits Units will be exchangeable into shares of Common Stock of the Issuer on a one-for-one basis after they have become vested and a sufficient amount of profits have been allocated to the holder of the Class B Profits Units.

The Reporting Person's Form 4 filings on each of February 4, 2025 and May 2, 2025 inadvertently overstated the number of Class B Profit Units granted to the Reporting Person as dividend equivalents by 419 and 432 Class B Profit Units, respectively. The total amount reported in Column 9 corrects the balance of the Reporting Person's account.


Includes shares acquired through dividend reinvestment plan.

/s/ Katherine L. Karel, Attorney-in-Fact for Michael G. Wooldridge


The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $178.23 to $178.53, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Includes Restricted Stock Units that have not yet vested.

The shares are owned by the Simpson Manufacturing Co., Inc. Profit Sharing Plan for Salaried Employees (the "Plan") of which the reporting person is a participant. The Plan qualifies under sections 401(a)(26) and 410 of the Internal Revenue Code.


Granted as a result of director's election to receive deferred stock units ("DSUs") in lieu of an annual cash retainer pursuant to Phreesia, Inc.'s Non-Employee Director Deferred Compensation Program. The DSUs are awarded on the date such annual cash retainer would otherwise be payable (i.e., quarterly in arrears). Director shall receive underlying common stock 90 days after director ceases to serve as a member of the Board of Directors of the Issuer and incurs a "separation from service" within the meaning of Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder.

/s/ Allison Hoffman by Power of Attorney for Lainie Goldstein


The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2024.


Moglia Peter M

C/O ALEXANDRIA REAL ESTATE EQUITIES, INC

Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock.


Common Stock

Common Stock

Common Stock

Shares acquired upon the vesting of November 1, 2022, November 1, 2023, and November 1, 2024 awards of service-based Restricted Stock Units.

Each Restricted Stock Unit represents a contingent right to receive one share of F5, Inc. Common Stock on the vest date.

This November 1, 2022 award of service-based Restricted Stock Units vests in twelve equal quarterly increments beginning February 1, 2023.

If the reporting person continues to provide services to the Company through the vest date, the corresponding number of shares of Common Stock of F5, Inc. will be issued to the reporting person on the vest date.

This November 1, 2023 award of service-based Restricted Stock Units vests in twelve equal quarterly increments beginning February 1, 2024.

This November 1, 2024 award of service-based Restricted Stock Units vests in twelve equal quarterly increments beginning February 1, 2025.


Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award.

Includes 682.498 shares of common stock acquired under the issuer's employee stock purchase plan in June 2025.


Grant of Restricted Stock Units in lieu of $36,250 quarterly cash retainer per the Registrant's Non-Employee Director Compensation Program. Delivery of shares deferred until 02/15/2028.

/s/ Elizabeth S. Campbell, attorney-in-fact for Werner Baumann


Shares withheld by the Company to satisfy tax withholding obligations upon vesting of RSUs; not an open market transaction.

Includes shares acquired pursuant to NIKE, Inc.'s Employee Stock Purchase Plan.

Shares held in account under the NIKE, Inc. 401(k) Savings and Profit Sharing Plan.

/s/ Kelsey A. Baldwin, attorney-in-fact for Mr. Leinwand


Common Stock

Shares withheld upon vesting of restricted stock to pay tax withholding obligations.

Represents matching options to purchase shares of the Company's common stock granted to the reporting person equal to the number of shares purchased by the reporting person on February 10, 2025 (the "Purchased Shares") pursuant to the Company's 2018 Employee Stock Option Grant Program. The options will vest on the second anniversary of the grant date, provided the reporting person remains a full-time employee of the Company and continues to hold the Purchased Shares, in each case, through the vesting date. The Purchased Shares were previously reported on the reporting person's Form 4 filed with the Securities and Exchange Commission on February 10, 2025.

/s/ Kristi O. Crawford, Attorney-in-Fact


The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.


The purchases reported herein were effected pursuant to a Rule 10b5-1 plan adopted by Hill City Holdings, LP ("Hill City") on June 5, 2025.

The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $14.55 to $14.93. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

The securities are held of record by Hill City. ECP ControlCo, LLC is the managing member of Energy Capital Partners IV, LLC, which is the general partner of Energy Capital Partners GP IV, LP, which is the general partner of each of (i) Energy Capital Partners IV-A, LP, (ii) Energy Capital Partners IV-B, LP, (iii) Energy Capital Partners IV-C, LP, and (iv) Energy Capital Partners IV-D, LP (the "Funds"). Energy Capital Partners GP IV, LP is also the general partner of Energy Capital Partners IV-B (Hill City IP), LP ("Hill City IP"). Each of (i) Energy Capital Partners IV-A, LP, (ii) Hill City IP, (iii) Energy Capital Partners IV-C, LP, and (iv) Energy Capital Partners IV-D, LP are the members of Hill City Holdings GP, LLC, which is the general partner of Hill City.

ECP ControlCo, LLC is controlled by its board of managers, which consists of Douglas Kimmelman, Peter Labbat, Tyler Reeder, Rahman D'Argenio, Raoul Hughes and Xavier Robert, all of whom collectively share the power to vote and dispose of the securities beneficially owned by ECP ControlCo, LLC. As a result of these relationships, each of the foregoing entities and individuals may be deemed to share beneficial ownership of the securities held of record by Hill City. Each such entity and individual disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein.

The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $12.29 to $13.29. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $13.30 to $14.25. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $14.35 to $14.54. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Due to filing limitations of the electronic filing system, each of ECP ControlCo, LLC, Energy Capital Partners IV, LLC, Energy Capital Partners GP IV, LP, Energy Capital Partners IV-A, LP, Energy Capital Partners IV-B, LP, Energy Capital Partners IV-C, LP, Energy Capital Partners IV-D, LP and Energy Capital Partners IV-B (Hill City IP), LP are filing a separate Form 4.


Due to filing limitations of the electronic filing system, each of ECP Fiber Holdings GP, LLC, ECP Fiber Holdings, LP, Hill City Holdings GP, LLC and Hill City Holdings, LP are filing a separate Form 4.


Common Stock, par value $0.0001 per share

/s/ Mike Lomenzo, Attorney-in-Fact for Lisa Keith


Common Stock par value $0.0001 per share

/s/ Mike Lomenzo, Attorney-in-Fact for Zine Mazouzi


Common Stock


The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 03/06/2025.

The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from  $25.920 to $26.338, inclusive.  The reporting person undertakes to provide MGIC Investment Corporation, any security holder of MGIC Investment Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.


/s/ Louis J. Thorson, Attorney-in-Fact for Ban Seng Teh


Represents stock units acquired pursuant to the Issuer's Stock Accumulation and Deferred Compensation Plan for Directors under which non-employee directors may elect to defer the payment of all or a specified portion of their cash compensation to be settled in CTVA common stock on a one-for-one basis on a future date selected by the Reporting Person at the time of his or her deferral election. Cash compensation deferred in the form of stock units is calculated based on the closing price of CTVA common stock on the date the cash compensation would have otherwise been payable.

Includes acquisition of 38.5152 shares pursuant to dividend reinvestment.

/s/Abigail Jarrell, by power-of-attorney


All transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 24, 2025.

These Ordinary Shares were sold in multiple trades at prices ranging from $148.80 to $148.94. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

These Ordinary Shares were sold in multiple trades at prices ranging from $150.31 to $151.03. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

These Ordinary Shares were sold in multiple trades at prices ranging from $151.98 to $152.78. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

These Ordinary Shares were sold in multiple trades at prices ranging from $153.53 to $154.50. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

These Ordinary Shares were sold in multiple trades at prices ranging from $155.01 to $155.85. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

These Ordinary Shares were sold in multiple trades at prices ranging from $156.15 to $157.05. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Includes 85 Ordinary Shares purchased by Reporting Person on July 31, 2025 under the Issuer's Employee Stock Purchase Plan. Such acquisition is exempt from reporting pursuant to Rule 16b-3 under the Securities Exchange Act of 1934.

/s/ Louis J. Thorson, Attorney-in-fact for James C. Lee


Granted as a result of director's election to receive deferred stock units ("DSUs") in lieu of an annual cash retainer pursuant to Phreesia, Inc.'s Non-Employee Director Deferred Compensation Program. The DSUs are awarded on the date such annual cash retainer would otherwise be payable (i.e., quarterly in arrears). Director shall receive underlying common stock on the earlier of (i) 90 days after ceasing to serve as a member of the Board of Directors of the Issuer and incurring a "separation from service" within the meaning of Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder, or (ii) five years from the date of grant of the DSUs.

/s/ Allison Hoffman as Attorney-in-Fact for Gillian Munson


All transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2025.

These Ordinary Shares were sold in multiple trades at prices ranging from $151.13 to $152.09. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Includes 202 Ordinary Shares purchased by Reporting Person on July 31, 2025 under the Issuer's Employee Stock Purchase Plan. Such acquisition is exempt from reporting pursuant to Rule 16b-3 under the Securities Exchange Act of 1934.

These Ordinary Shares were sold in multiple trades at prices ranging from $152.15 to $153.11. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

These Ordinary Shares were sold in multiple trades at prices ranging from $153.17 to $154.16. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

These Ordinary Shares were sold in multiple trades at prices ranging from $154.17 to $155.07. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

These Ordinary Shares were sold in multiple trades at prices ranging from $155.22 to $156.19. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

These Ordinary Shares were sold in multiple trades at prices ranging from $156.22 to $156.54. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

/s/ Louis J. Thorson, Attorney-in-Fact for William D. Mosley


Common Stock

Shares acquired upon vesting of the November 1, 2024 award of service-based Restricted Stock Units.

Each Restricted Stock Unit represents a contingent right to receive one share of F5, Inc. Common Stock on the vest date.

This November 1, 2024 award of service-based Restricted Stock Units vests in twelve equal quarterly beginning February 1, 2025.

If the reporting person continues to provide services to the Company through the vest date, the corresponding number of shares of Common Stock of F5, Inc. will be issued to the reporting person on the vest date.

/s/ Joseph P. McDermott by Power of Attorney


Stock granted as independent director compensation, issued under the issuer's 2021 Equity Incentive Plan.

/s/ Daniel Hoeft, attorney-in-fact for Walter S. Woltosz and Virginia E. Woltosz


Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

This transaction represents an exchange of Common Stock for Class A Common Stock.

Performance Restricted Stock Units ("PRSUs") award granted 1/26/2023. Each PRSU represents a contingent right to receive one share of HVT common stock and was earned based on EBITDA for the year ended December 31, 2023, and will vest on February 28, 2026.

Performance Restricted Stock Units ("PRSUs") award granted 1/26/2023. Each PRSU represents a contingent right to receive one share of HVT common stock and was earned based on consolidated sales for the year ended December 31, 2023, and will vest on February 28, 2026.

Performance Restricted Stock Units ("PRSU") award granted 01/25/2024. Each PRSU represents a contingent right to receive one share of HVT common stock and was earned based on EBITDA for the year ended December 31, 2024, and will vest on February 28, 2027.

Restricted Stock Units granted 1/26/2023 and vest ratably over 3 years beginning 5/8/2024. Each RSU is equivalent to one share of common stock upon vesting.

Restricted Stock Units granted 1/25/2024 and vest ratably over 3 years beginning 5/8/2025. Each RSU is equivalent to one share of common stock upon vesting.

Restricted Stock Units granted 1/23/2025 and vest ratably over 3 years beginning 5/8/2026. Each RSU is equivalent to one share of common stock upon vesting.

Deferred under Directors' Deferred Compensation Plan.  Settlement will occur as prescribed by the elections under the Plan.


Granted as a result of director's election to receive deferred stock units ("DSUs") in lieu of an annual cash retainer pursuant to Phreesia, Inc.'s Non-Employee Director Deferred Compensation Program. The DSUs are awarded on the date such annual cash retainer would otherwise be payable (i.e., quarterly in arrears). Director shall receive underlying common stock on the earlier of (i) 90 days after ceasing to serve as a member of the Board of Directors of the Issuer and incurring a "separation from service" within the meaning of Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder, or (ii) five years from the date of grant of the DSUs.

/s/ Allison Hoffman by Power of Attorney for Ed Cahill


Shares withheld by the Company to satisfy tax withholding obligations upon vesting of RSUs; not an open market transaction.

Includes shares acquired pursuant to NIKE, Inc.'s Employee Stock Purchase Plan.

Shares held in account under the NIKE, Inc. 401(k) Savings and Profit Sharing Plan.

/s/ Kelsey A. Baldwin, attorney-in-fact for Ms. Montagne


The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 13, 2025.

Reflects the weighted average price of 2,000 common shares sold by the reporting person in multiple transactions on August 1, 2025 with sale prices ranging from $1.885 to $1.930 per share.  The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

/s/ Beth Taylor, Attorney-in-Fact for R. Matthew Neff


Common Stock

Includes shares of restricted stock which vest at a rate of 20% per year commencing on August 26, 2023.

Stock options vest at a rate of 20% per year commencing on August 26, 2023.

/s/ Kelly Pecoraro, pursuant to Power of Attorney


Represents stock units acquired pursuant to the Issuer's Stock Accumulation and Deferred Compensation Plan for Directors under which non-employee directors may elect to defer the payment of all or a specified portion of their cash compensation to be settled in CTVA common stock on a one-for-one basis on a future date selected by the Reporting Person at the time of his or her deferral election. Cash compensation deferred in the form of stock units is calculated based on the closing price of CTVA common stock on the date the cash compensation would have otherwise been payable.

Includes acquisition of 72.7656 shares pursuant to dividend reinvestment.


Grant of Restricted Stock Units received in lieu of $30,000 quarterly cash retainer per the Registrant's Non-Employee Compensation Program. Delivery of shares deferred until 03/01/2030.

/s/ Elizabeth S. Campbell, attorney-in-fact for Lauren M. Tyler


Stock granted as independent director compensation, issued under the issuer's 2021 Equity Incentive Plan.

/s/ Daniel Hoeft, attorney-in-fact for Daniel L. Weiner


Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

This transaction represents an exchange of Common Stock for Class A Common Stock.

Performance Restricted Stock Units ("PRSUs") award granted 1/26/2023. Each PRSU represents a contingent right to receive one share of HVT common stock and was earned based on EBITDA for the year ended December 31, 2023, and will vest on February 28, 2026.

Performance Restricted Stock Units ("PRSUs") award granted 1/26/2023. Each PRSU represents a contingent right to receive one share of HVT common stock and was earned based on consolidated sales for the year ended December 31, 2023, and will vest on February 28, 2026.

Performance Restricted Stock Units ("PRSU") award granted 01/25/2024. Each PRSU represents a contingent right to receive one share of HVT common stock and was earned based on EBITDA for the year ended December 31, 2024, and will vest on February 28, 2027.

Restricted Stock Units granted 1/26/2023 and vest ratably over 3 years beginning 5/8/2024. Each RSU is equivalent to one share of common stock upon vesting.

Restricted Stock Units granted 1/25/2024 and vest ratably over 3 years beginning 5/8/2025. Each RSU is equivalent to one share of common stock upon vesting.

Restricted Stock Units granted 1/23/2025 and vest ratably over 3 years beginning 5/8/2026. Each RSU is equivalent to one share of common stock upon vesting.


Common Stock

Includes 15,922 restricted stock grant shares that have not yet vested.

Stock options vest ratably for seven years commencing on October 19, 2023.


Grant of restricted shares of Common Stock under the Brookdale Senior Living Inc. 2024 Omnibus Incentive Plan. The shares will vest on April 24, 2026, subject to continued service.


/s/ Daniel Hoeft, attorney-in-fact for John Kenneth Paglia


Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock


Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of restricted stock units vested as of August 1, 2025.

These shares include 7,225 shares that were purchased on June 30, 2025, due to participation by the reporting individual in the issuer's 2018 Employee Stock Purchase Plan


By Charles R. McCulloch Trust dated 1990

These shares include 7,225 shares that were purchased on June 30, 2025 due to participation by the reporting individual in the issuer's 2018 Employee Stock Purchase Plan.

The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.


Burke Mary Lou

C/O BRIGHT HORIZONS FAMILY SOLUTIONS INC

The transactions were made pursuant to a trading plan intended to comply with Rule 10b5-1(c) previously adopted by the Reporting Person on December 12, 2024.

/s/ John Casagrande, as attorney in fact for Mary Lou Burke


Common Stock

Award of stock units representing dividend equivalents on amounts previously deferred under the Company's Amended and Restated Outside Directors' Deferred Compensation Plan. Shares of Common Stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Issuer.

/s/ David Latchana, by Power of Attorney


Stock granted as independent director compensation, issued under the issuer's 2021 Equity Incentive Plan.

/s/ Daniel Hoeft, attorney-in-fact for Sharlene Evans


The shares were purchased pursuant to a dividend reinvestment program offered through a brokerage account maintained by the reporting person.

Amount includes 128.6327 shares acquired with reinvested dividends pursuant to the First United Corporation Dividend Reinvestment and Stock Purchase Plan since the date of the last report.

Amount includes 0.5447 shares acquired with reinvested dividends pursuant to the First United Corporation Dividend Reinvestment and Stock Purchase Plan since the date of the last report.

Amount includes 6.2775 shares acquired with reinvested dividends pursuant to the First United Corporation Dividend Reinvestment and Stock Purchase Plan since the date of the last report.


Common Stock


Common Shares, $.0011 par value per share

Each Depositary Share Represents 1/1,000th interest in a Series G Non-Cumulative Preferred Share.

Each Depositary Share Represents 1/1,000th interest in a Series F Non-Cumulative Preferred Share.


Surrender of shares to satisfy tax withholding obligation incident to vesting of restricted stock.


The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on February 27, 2025.


Common Stock

Each restricted stock unit ("RSU") represents a contingent right to receive either one share of common stock of the Issuer ("Common Stock") or an amount of cash equal to the fair market value of
one share of Common Stock. The RSUs will vest in three substantially equal annual installments commencing on August 1, 2026.

/s/ John J. Mitchell, as attorney-in-fact for Caleb Lyle Weatherl


Ordinary Shares

Ordinary Shares

Represents shares issued upon the settlement of performance-vesting restricted stock units granted on August 1, 2022 and earned dividend equivalents.

Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 1, 2025.

Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I.

Each performance share unit represents a contingent right to receive one share of Medtronic common stock.

The performance share units vested on August 1, 2025.

These options became exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.

/s/ Patricia Walesiewicz, attorney-in-fact


Class A Common Stock

Class A Common Stock

Class A Common Stock

Class A Common Stock

Class A Common Stock

The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 4, 2025 by the Reporting Person.

The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the options vesting on April 19, 2022 and the remaining 75% of the options vesting monthly thereafter.

The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting on March 24, 2022, and 1/48th of the options vesting monthly thereafter.

The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting on September 10, 2022, and 1/48th of the options vesting monthly thereafter.

The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting monthly, beginning on April 1, 2023.

/s/ Alexandra Cotter Wilkins, Attorney-in-Fact


Stock granted as independent director compensation, issued under the issuer's 2021 Equity Incentive Plan.

The sales reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person.

These shares were sold in a single transaction at $12.93.

/s/ Daniel Hoeft, attorney-in-fact for Lisa LaVange


Common Stock

Represents Restricted Stock Units ("RSUs") granted to the Reporting Person on August 4, 2025 under the Fortrea Holdings Inc. 2025 Inducement Award Plan. Each RSU represents the right to receive, at settlement, one share of Fortrea Holdings Inc. Common Stock.

The RSUs vest in three equal annual installments beginning on August 4, 2026.

/s/ James Stillman Hanson, Attorney-in-Fact for Anshul Thakral


This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on July 31, 2024.

/s/ Chad A. Keetch, as power of attorney


Common Stock

Award of stock units representing dividend equivalents on amounts previously deferred under the Company's Amended and Restated Outside Directors' Deferred Compensation Plan. Shares of Common Stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Issuer.


Performance Share Unit

Represents shares issued upon the settlement of performance-vesting restricted stock units granted on August 1, 2022 and earned dividend equivalents.

Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 1, 2025.

Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I.

Each performance share unit represents a contingent right to receive one share of Medtronic common stock.

The performance share units vested on August 1, 2025.


Performance Share Units


Represents shares withheld to cover payment of the tax liabilities of the reporting person related to a restricted stock unit (RSU) award granted 7/30/2024. The award of the RSU was previously reported in Table I of reporting person's Form 4 filed on 8/1/2024.

/s/ Kurt E. Scheuerman, Attorney-in-Fact


Common Stock

Restricted stock units convert into shares of Common Stock on a one-for-one basis.

On July 31, 2023, the Reporting Person was granted 39,464 restricted stock units, vesting as follows, subject to the Reporting Person's continued employment: one-third on each of the first, second, and third year anniversaries of the grant date.


Performance Share Unit

Ordinary Shares

Represents shares withheld for taxes upon the vesting of restricted stock units previously reported on Table I.

These options became exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.


/s/Heidi A. Sepanik, Corporate Secretary, Visteon Corporation on behalf of Brett D. Pynnonen


This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 2, 2025.


Performance Share Units

Ordinary Shares


The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.


Common Stock

Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.

The restricted stock units vest in three installments, 952 on August 1, 2025, 981 on August 1, 2026, and 952 on August 1, 2027.

/s/ Jonathan Groff for Melissa Seymour, pursuant to authorization on file


Ordinary Shares


Shares withheld by the Company to satisfy tax withholding obligations upon vesting of RSUs; not an open market transaction.

Includes shares acquired pursuant to NIKE, Inc.'s Employee Stock Purchase Plan.

/s/ Kelsey A. Baldwin, attorney-in-fact for Mr. Williams


The price reported in Column 4 is a weighted average price. These share were sold in multiple transactions at prices ranging from $72.78 to $73.1150 inclusive. The reporting person undertakes to provide AAR CORP., any security holder of AAR CORP., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.


This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 28, 2025.

/s/ P. Diana Chiu, attorney-in-fact for Mr. McDonnell


Ordinary Shares

Ordinary Shares

Ordinary Shares

Represents shares issued upon the settlement of performance-vesting restricted stock units granted on August 1, 2022 and earned dividend equivalents.

Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 1, 2025.

Represents shares issued upon the settlement of performance-vesting restricted stock units granted on October 31, 2022 and earned dividend equivalents.

Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I.

Each performance share unit represents a contingent right to receive one share of Medtronic common stock.

The performance share units vested on August 1, 2025.


Ordinary Shares

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person December 6, 2024.

This transaction was executed in multiple trades at prices ranging from $41.48 to $42.46. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

This transaction was executed in multiple trades at prices ranging from $42.47 to $42.51. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

/s/ Shanti Ariker pursuant to power of attorney


Common Stock

Common Stock

Common Stock

Common Stock

Each restricted stock unit represents a contingent right to receive one share of SPGI common stock.

As previously reported, the reporting person was granted 1,197 restricted stock units on 08/01/2022, subject to 3-year vesting. The restricted stock units vested 33% on 08/01/2023, 33% on 08/01/2024 and the remaining 34% vested on 08/01/2025.

As previously reported, the reporting person was granted 399 restricted stock units on 03/01/2023, subject to 3-year vesting. The restricted stock units vested 33% on 12/31/2023 and 33% on 12/31/2024 and the remaining 34% will vest on 12/31/2025. Vested shares will be delivered to the reporting person no later than January 31 following the respective vesting date.

As previously reported, the reporting person was granted 366 restricted stock units on 03/01/2024, subject to 3-year vesting. The restricted stock units vested 33% on 12/31/2024 and will vest 33% on 12/31/2025 and 34% on 12/31/2026. Vested shares will be delivered to the reporting person no later than January 31 following the respective vesting date.

As previously reported, the reporting person was granted 1,009 restricted stock units on 03/01/2025, subject to 3-year vesting. The restricted stock units will vest 33% on 12/31/2025, 33% on 12/31/2026 and 34% on 12/31/2027. Vested shares will be delivered to the reporting person no later than January 31 following the respective vesting date.


Common Stock

Pursuant to option schedule wherein 20% of the aggregate number of shares granted may be exercised commencing one year from grant date and each year thereafter in 20% increments.


Common Stock


Securities herein were allocated pursuant to the RLI Corp. Non-Employee Directors Deferred Compensation Plan.

Adjusted to reflect 2-for-1 stock split on 01/15/25.


Ownership reflects dividend reinvestment.


Ownership reflects dividend reinvestment


Common Stock

Represents settlement of restricted stock units ("RSUs") through the issuance of one share of Common Stock for each vested RSU.

Represents shares of Common Stock withheld by the Issuer to cover tax withholding obligations upon the vesting of RSUs.

On July 31, 2023, the Reporting Person was granted 1,983 RSUs, generally vesting in three installments of approximately 33 1/3% on each of July 31, 2024, July 31, 2025 and July 31, 2026.

The RSUs were granted to the Reporting Person pursuant to the Taylor Morrison 2013 Omnibus Equity Award Plan, as amended.


Represents performance-based restricted stock, which may be earned between 0% and 200% of the target amount reported herein based upon the Issuer's actual performance as compared with an adjusted EBITDA target during the three-year period from December 29, 2024 through December 25, 2027.  The vesting date is July 30, 2028.


Represents performance-based restricted stock, which may be earned between 0% and 200% of the target amount reported herein based upon the Issuer's actual performance as compared with an adjusted EBITDA target during the three-year period from December 29, 2024 through December 25, 2027.  The vesting date is July 30, 2030.


Surrender of shares to satisfy tax withholding obligation incident to vesting of restricted stock.


Represents common stock withheld for taxes related to restricted stock units which vest in twelve equal installments on the first day of each month following the grant date.


Michael E. Montifar, attorney-in-fact for Lynn A. Dugle


Acquired through the Company's Restricted Stock Program.  Shares vest equally on anniversary in years one, two and three.


Total number of shares reflects periodic purchase activity in the Company's 401(k) plan (totaling 35 shares) between January, 2025 and the disposition of 3,746 shares on the transaction date.


Common Stock

Deferred stock units acquired pursuant to the AT&T Inc. Non-Employee Director Stock and Deferral Plan. After the reporting person ceases to be a director, each unit is paid out in cash equal to the value of one share of AT&T common stock at times elected by the director.

/s/ Johnell C. Holland, Attorney-in-fact


Common Stock

Restricted stock units convert into common stock on a one-for-one basis.

On August 1, 2023, the reporting person was granted 14,188 restricted stock units, vesting in four annual installments of 15%, 20%, 30%, and 35% beginning August 1, 2024, the first anniversary of the grant date.


/s/ Matthew C. Tomb POA for Todd D. Brice


Michael E. Montifar, attorney-in-fact for Robert P. Daniels


The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted December 31, 2024.

The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $35.60 to $36.57, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.

Certain of these securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each RSU.

The number of shares held reflects the transfer of 17,793 shares of Class A Common Stock from The Phillips Family Trust dated 5/9/2013, of which the Reporting Person and his spouse serve as trustees (the "Phillips Family Trust"), to the Reporting Person.

The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $36.60 to $37.11, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.

Consists of shares held by the Phillips Family Trust.

Executive Vice President, Chief Financial Officer

/s/ Adam Eltoukhy, attorney-in-fact on behalf of Dominic Phillips


Common Stock


Common Stock

Each deferred stock unit represents a right to receive one share of the Issuer's common stock.

The reported shares represent deferred stock units issued in lieu of the Issuer's monthly dividend pursuant to the reporting person's election.

The deferred stock units are 100% vested but do not become payable until the earlier to occur of a change of control or the reporting person's death, disability, or separation from service as a director of the Issuer.


Represents additional shares of phantom stock/RSUs credited to the reporting person's account under the Amended and Restated GATX Directors' Phantom Stock Plan ("Phantom Stock Plan") and the Amended and Restated GATX Corporation Directors' Voluntary Deferred Fee Plan ("Deferred Fee Plan") credited on the transaction date. Each share of phantom stock/RSU represents the right to receive one share of Issuer's common stock upon settlement. The shares of phantom stock/RSUs are generally payable on a deferred basis in common stock at the election of the reporting person upon the reporting person's termination of service on the Issuer's board of directors.

Represents 73 shares of phantom stock/RSUs acquired pursuant to the dividend reinvestment feature of the Phantom Stock Plan and the Deferred Fee Plan.

Lisa M. Ibarra, by Power of Attorney on behalf of Diane M. Aigotti


The transaction was pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.


Common Shares, par value $0.001 per share

Director's compensation


Depositary Shares (Preferred Stock, Series C)

Common Stock

Each Depositary Share represents a 1/1,000h interest in a share of 4.750% Perpetual Preferred Stock, Series C.


Michael E. Montifar, attorney-in-fact for Charles R. Crisp


Director's compensation


Performance-Based Restricted Stock Units ("2022 PSUs")

Common Stock

On July 26, 2022, the reporting person was granted 1,412,429 of 2022 PSUs, with vesting subject to the achievement of certain pre-established performance parameters relating to the aggregate EBITDA generated from the HEXO transaction. The underlying performance condition was satisfied, and 353,108 units vested on July 31, 2025.

Amount includes shares of Common Stock beneficially owned by the reporting person but excludes other unvested RSUs.

Represents shares withheld by the Company to satisfy the tax withholding obligation associated with the vesting of 353,108 of 2022 PSUs previously granted on June 26, 2022.

Each unit represents a contingent right to receive one (1) share of Tilray Common Stock.

/s/ Carl A. Merton, as Attorney-in-Fact for Irwin D Simon


Common Stock

Deferred stock units acquired pursuant to the AT&T Inc. Non-Employee Director Stock and Deferral Plan. After the reporting person ceases to be a director, each unit is paid out in cash equal to the value of one share of AT&T common stock at times elected by the director.


The sales reported on this Form 4 were effected pursuant to a previously announced Rule 10b5-1 trading plan adopted by the Jesse K. Bray Living Trust (the "Trust") on June 13, 2024.

The price reported in Column 4 is a weighted average price; the shares were sold in multiple transactions at prices ranging from $163.99 to $180.32, inclusive. Reporting Person, on behalf of the Trust, undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

/s/Katherine K. Connell, Attorney-in-Fact


These shares were purchased due to participation by the reporting individual in the Issuer's 2019 Employee Stock Purchase Plan ("ESPP"). It pertains to the ESPP purchase period from February 1, 2025 through July 31, 2025.

In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 31, 2025.


Common Stock

On July 26, 2022, the reporting person was granted 187,853 of 2022 PSUs, with vesting subject to the achievement of certain pre-established performance parameters relating to the aggregate EBITDA generated from the HEXO transaction. The underlying performance condition was satisfied, and 46,964 units vested on July 31, 2025.

Represents shares withheld by the Company to satisfy the tax withholding obligation associated with the vesting of 46,964 of 2022 PSUs previously granted on June 26, 2022.


Common Stock

On July 31, 2025, the reporting person purchased 6,000 shares of common stock of Tilray Brands, Inc. on the open market at a per share price of $0.5827.


These shares were purchased due to participation of the reporting individual in the Issuer's 2019 Employee Stock Purchase Plan ("ESPP"). It pertains to the ESPP purchase period from February 1, 2025 through July 31, 2025.

In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock.


The Reporting Person sold, in multiple transactions, common shares at prices ranging from $60.00 to $61.56.


Class I Common Stock, par value $0.001 per share

These shares of common stock of KKR Real Estate Select Trust Inc. ("Common Stock") were issued as payment for management and/or incentive fees pursuant to the investment advisory agreement between KKR Real Estate Select Trust Inc. and KKR Registered Advisor LLC. Pursuant to such investment advisory agreement, KKR Registered Advisor LLC directed that KKR Alternative Assets LLC, its affiliate, receive these shares on its behalf.

The Common Stock is held by KKR Alternative Assets LLC. KKR Group Assets Holdings II L.P. is the sole member of KKR Alternative Assets LLC. KKR Group Assets II GP LLC is the general partner of KKR Group Assets Holdings II L.P. KKR Group Partnership L.P. is the sole member of KKR Group Assets II GP LLC. KKR Group Holdings Corp. is the general partner of KKR Group Partnership L.P. KKR Group Co. Inc. is the sole shareholder of KKR Group Holdings Corp. KKR & Co. Inc. is the sole shareholder of KKR Group Co. Inc. KKR Management LLP is the Series I preferred stockholder of KKR & Co. Inc. Messrs. Henry R. Kravis and George R. Roberts are the founding partners of KKR Management LLP.

Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein.


Common Stock


Disposition of shares back to the company to satisfy withholding obligations related to stock awards vesting August 1, 2025

Melissa Garrett as agent for Kevin Speirits


Charitable gift.

/s/ John Guthrie, attorney-in-fact for Doug Black


Common Stock

Common Stock

Represents acquisition of common stock upon vesting of restricted stock units.

Represents the sale of securities on the open market to satisfy the tax obligation upon the vesting of restricted stock units pursuant to the terms of the award agreement.

Each restricted stock unit represents the right to receive one share of the Issuer's common stock.

/s/ Laura Anne Kenwick, as-attorney-in-fact


/s/ Robert P. Ryder, by Brandon Rykkeli, attorney-in-fact


Represents a sale of shares to satisfy tax obligations arising from the vesting of restricted shares of stock.

The Power of Attorney dated August 31, 2022, is incorporated herein by reference.


Shares withheld by Quanterix Corporation solely to cover tax obligations upon the vesting of 761 RSUs.

Includes 232,535 restricted stock units.


Common Stock

Common Stock

Common Stock

Exercise and sale of shares pursuant to a Rule 10b5-1 plan adopted by Mr. Fauber on July 30, 2024.

One fourth of the options vest each year beginning with the date indicated.

Elizabeth McCarroll, by power of attorney for Robert Fauber


Common Stock

Common Stock

The Employee Stock Options were granted under the 2016 Stock Incentive Plan with all units fully vested.


Michael E. Montifar, attorney-in-fact for Michael P. Donaldson


Amount includes 71 shares purchased under the 2016 Employee Stock Purchase Plan for the offering period ending January 31, 2025 and 64 shares purchased under the 2016 Employee Stock Purchase Plan for the offering period ending July 31, 2025.

/s/Catherine Gorecki by power of attorney filed 01/25/2024


Represents number of securities owned by EN Holdings LLC, which is owned by the reporting person and his affiliates.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.64 to $66.63. The Reporting Person undertakes to provide Interactive Brokers Group, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes (2) - (7) to this Form 4.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.64 to $66.72.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.35 to $63.34.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.35 to $64.34.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.35 to $65.34.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.35 to $65.79.

This amount includes (a) Class A common stock attributable to vested restricted stock units that were awarded under the amended 2007 Stock Incentive Plan ("Plan") and (b) unvested restricted stock units that were awarded under the Plan.

/s/ Raymond Bussiere as authorized signatory for Earl H. Nemser


Common Stock

Each restricted stock unit represents a contingent right to receive one share of Issuer's Common Stock.

Adjusted to reflect a 1-for-10 reverse stock split that occurred on June 10, 2025.


Michael E. Montifar, attorney-in-fact for Jeffrey R. Leitzell


Represents additional shares of phantom stock/RSUs credited to the reporting person's account under the Amended and Restated GATX Directors' Phantom Stock Plan ("Phantom Stock Plan") and the Amended and Restated GATX Corporation Directors' Voluntary Deferred Fee Plan ("Deferred Fee Plan") credited on the transaction date. Each share of phantom stock/RSU represents the right to receive one share of Issuer's common stock upon settlement. The shares of phantom stock/RSUs are generally payable on a deferred basis in common stock at the election of the reporting person upon the reporting person's termination of service on the Issuer's board of directors.

Represents 136 shares of phantom stock/RSUs acquired pursuant to the dividend reinvestment feature of the Phantom Stock Plan and the Deferred Fee Plan.

Lisa M. Ibarra, by Power of Attorney on behalf of Paul G. Yovovich


Non-Qualified Stock Option (Right to Buy)

Woodward, Inc. Common Stock

Woodward, Inc. Common Stock

Total includes 4 additional shares and units issued in connection with the dividend reinvestment provisions of the Issuer's RSU awards.

The reporting person executed a trade order through a broker-dealer which resulted in multiple same day, same way open market sales, with prices ranging from $257.22 to $257.90 per share. The reporting person has reported these sales on an aggregate basis using the weighted average price for the transactions. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Company or a security holder of the Company, full information regarding the number of shares sold at each separate price.

The reporting person executed a trade order through a broker-dealer which resulted in multiple same day, same way open market sales, with prices ranging from $258.32 to $259.19 per share. The reporting person has reported these sales on an aggregate basis using the weighted average price for the transactions. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Company or a security holder of the Company, full information regarding the number of shares sold at each separate price.

The reporting person executed a trade order through a broker-dealer which resulted in multiple same day, same way open market sales, with prices ranging from $259.47 to $259.96 per share. The reporting person has reported these sales on an aggregate basis using the weighted average price for the transactions. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Company or a security holder of the Company, full information regarding the number of shares sold at each separate price.

The reporting person executed a trade order through a broker-dealer which resulted in multiple same day, same way open market sales, with prices ranging from $260.56 to $261.33 per share. The reporting person has reported these sales on an aggregate basis using the weighted average price for the transactions. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Company or a security holder of the Company, full information regarding the number of shares sold at each separate price.

The reporting person executed a trade order through a broker-dealer which resulted in multiple same day, same way open market sales, with prices ranging from $261.86 to $262.77 per share. The reporting person has reported these sales on an aggregate basis using the weighted average price for the transactions. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Company or a security holder of the Company, full information regarding the number of shares sold at each separate price.

The reporting person executed a trade order through a broker-dealer which resulted in multiple same day, same way open market sales, with prices ranging from $263.13 to $263.97 per share. The reporting person has reported these sales on an aggregate basis using the weighted average price for the transactions. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Company or a security holder of the Company, full information regarding the number of shares sold at each separate price.

The reporting person executed a trade order through a broker-dealer which resulted in multiple same day, same way open market sales, with prices ranging from $264.14 to $264.35 per share. The reporting person has reported these sales on an aggregate basis using the weighted average price for the transactions. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Company or a security holder of the Company, full information regarding the number of shares sold at each separate price.

Options are fully vested and exercisable.


Michael E. Montifar, attorney-in-fact for C. Christopher Gaut


Michael E. Montifar, attorney-in-fact for Michael T. Kerr


/s/ Gail Corrigan, pursuant to power of attorney


Michael E. Montifar, attorney-in-fact for Ezra Y. Yacob


Represents 167 shares of phantom stock/RSUs acquired pursuant to the dividend reinvestment feature of the Phantom Stock Plan and the Deferred Fee Plan.

Lisa M. Ibarra, by Power of Attorney on behalf of James B. Ream


By Employee Stock Ownership & Savings Plan

COMMON STOCK

COMMON STOCK

COMMON STOCK

COMMON STOCK

COMMON STOCK

Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable, in cash or common stock, at the election of the reporting person, upon the reporting person's termination of employment.

Each restricted stock unit represents a contingent right to receive one share of First Community Bankshares Inc. common stock, or at the reporting persons election, the cash value thereof. The restricted stock units cliff vest on May 23, 2026 based on First Community Bankshares, Inc. satisfaction of certain performance criteria for the three years ending March 31, 2026 and the continued employment of the reporting person.

Stock options vest in three equal installments over three years beginning with 03/31/2022.

Each restricted stock unit represents a contingent right to receive one share of First Community Bankshares Inc. common stock, or at the reporting persons election, the cash value thereof. The restricted stock units cliff vest on May 29, 2027 based on First Community Bankshares, Inc. satisfaction of certain performance criteria for the three years ending March 31, 2027 and the continued employment of the reporting person.

Each restricted stock unit represents a contingent right to receive one share of First Community Bankshares Inc. common stock, or at the reporting persons election, the cash value thereof. 30% of the restricted stock units cliff vest on May 28, 2028, and 70% of the units vest based on First Community Bankshares, Inc. satisfaction of certain performance criteria for the three years ending March 31, 2028.  All vesting is contingent upon the continued employment of the reporting person.

David D. Brown by: Sarah W. Harmon (His Attorney-in-Fact)


This transaction was made pursuant to a trading plan adopted November 15, 2024 , intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Securities Exchange Act of 1934.

/s/ Stathy Darcy by Power of Attorney for Dino E. Robusto


Reflects transactions not required to be reported pursuant to Section 16 of the Securities Exchange Act of 1934, as amended.

/s/Chao Huang, Pursuant to Power of Attorney


Common Stock

Reports the number of Restricted Stock Units, exempt under Section 16(b), granted and credited to the account of the reporting person on July 31, 2025, specified under the terms of the Norfolk Southern Corporation Long-Term Incentive Plan. Each Unit is the economic equivalent of one share of Common Stock. These Units will be settled in Norfolk Southern Corporation Common Stock, vesting in full on the first anniversary of the grant date.

J. Jeremy Ballard via P.O.A. for Richard H. Anderson


Common Stock

Reports the number of Restricted Stock Units, exempt under Section 16(b), granted and credited to the account of the reporting person on July 29, 2024, specified under the terms of the Norfolk Southern Corporation Long-Term Incentive Plan. Each Unit is the economic equivalent of one share of Common Stock. These Units were settled in Norfolk Southern Corporation Common Stock, vesting in full on the first anniversary of the grant date. This distribution represents the sole installment.

J. Jeremy Ballard via P.O.A. for Gilbert H. Lamphere


Represents weighted average price.

Mr. Shaw has investment power over 500,000 shares as Trustee for the benefit of a family member. Mr. Shaw has voting control over the remainder of the shares pursuant to a voting agreement.

The Rule 10b5-1 Plan's date of adoption was August 22, 2024.


Vest of restricted stock shares.

Includes 7,324 restricted shares that vest monthly in equal installments through April 1, 2027, 11,436 restricted stock units that vest on 2/22/2027, 11,069 restricted stock units that vest on 2/16/2026,
and 110,596 shares owned outright.

Represents shares held of record by the Gregg Sengstack 2020 Dynasty Trust, for which the reporting person's spouse is the trustee and over which the reporting person does not have sole voting and investment power.

Represents shares held of record by the Dianne Sengstack 2020 Dynasty Trust, for which the reporting person is the trustee and over which the reporting person has sole voting and investment power.

Represents shares held of record by the Sengstack Family Foundation, for which the reporting person is the president and over which the reporting person has sole voting and dispositive power.

Jonathan M. Grandon, power of attorney for Gregg C. Sengstack


These shares were retained by the Issuer in order to meet the tax withholding obligations of the Reporting Person in connection with the vesting of an installment of the restricted stock units. The amount retained by the Issuer was not in excess of the amount of the tax liability.


/s/ Jeffrey J. Pochowicz, Attorney-in-fact


Common Stock,  $0.01 par value per share

Shares relinquished to cover tax obligations on vesting of 280 shares of restricted stock pursuant to the 2018 Omnibus Incentive Plan.

Market price on August 1, 2025.


The shares were purchased pursuant to a dividend reinvestment program offered through a brokerage account maintained by the reporting person.

Amount includes 78.3939 shares acquired with reinvested dividends pursuant to the First United Corporation Dividend Reinvestment and Stock Purchase Plan since the date of the last report.


INCLUDES 1,140.4272 SHARES ACQUIRED THROUGH THE DIVIDEND REINVESTMENT PLAN.


Common Stock

The reporting person is enrolled in quarterly dividend reinvestment. The beneficially owned shares have been adjusted to reflect shares purchased through the reinvestment plan.

The option vests in three annual installments beginning on the first anniversary of the date of grant.


/s/ Carissa L. Rodeheaver, attorney-in-fact


A portion of the Reporting Person's restricted stock units (13,655) granted on August 1, 2024, vested on August 1, 2025.  Upon vesting, 6,193 restricted stock units were withheld to satisfy the Reporting Person's tax liability.

/s/ David C. House, Attorney-in-Fact for William Fehrman


1,064 restricted shares vest 1 year after the 7/7/2025 hire date, 1,064 restricted shares vest 2 year after the 7/7/2025 hire date and 1,065 restricted shares vest 3 year after the 7/7/2025 hire date.

Includes 1,064 restricted shares that vest on 7/7/2026, 1,064 restricted shares that vest on 7/7/2027 and 1,065 restricted shares that vest 3 on 7/7/2028.


6,440 restricted shares vest 1 year after the 7/7/2025 hire date and 5,269 restricted shares that vest 2 years after the 7/7/2025 hire date.

Includes 6,440 restricted shares that vest on 7/7/2026 and 5,269 restricted shares that vest on 7/7/2027.


Common Stock

Units credited as part of Director Compensation Plan.

Shares issuable following termination of service as a director

Includes 106 shares credited to account based on dividends paid on June 15, 2025

/s/ Katherine L. Karel, Attorney-in-Fact for Brian C. Walker


Represents shares sold pursuant to a 10b5-1 Sales Plan entered into between Reporting Person and Broker on June 14, 2025.


Includes shares acquired through dividend reinvestment plan.

Katherine L. Karel, Attorney-In-Fact for Mary Tuuk Kuras


Includes restricted stock bonus shares, subject to vesting and forfeiture.


Common Stock

Includes 211 shares credited based on dividend paid on June 15, 2025

Katherine L. Karel, Attorney-in-Fact for Thomas Wayne Rhodes


Bonafide gift.

/s/Marlene A. Krumholz as Attorney-in-Fact for Endeavor Foundation, Inc.


Common Stock

Common Stock

The shares were sold in multiple transactions at prices ranging from $76.39 to $76.74 per share on August 1, 2025.  The $76.59273 sale price reported above is the weighted average sale price.  The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

The shares were sold in multiple transactions at prices ranging from $76.36 to $76.83 per share on August 1, 2025.  The $76.519824 sale price reported above is the weighted average sale price.  The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

The option vests in three equal installments on February 19, 2021, 2022, and 2023.

The option vests in three equal installments on February 17,  2022, 2023, and 2024.

Jessica Vu, Attorney-in-Fact for Sumner J. Waring, III


Common Stock

The phantom stock units were accrued under the Company's Deferred Compensation Plan and are payable in shares of the Company's common stock until the reporting person's death, disability or retirement.

Includes 40 shares credited to account based on dividends paid on June 15, 2025

/s/ Katherine L. Karel, Atty-In-fact for Benjamin J. McLean


Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

These units (acquired after 12-31-04) convert into shares of common stock on a 1-for-1 basis.

These units (acquired after 12-31-04) convert into shares of common stock upon the earlier of certain termination events as specified in the Key Employee Deferred Compensation Plan or such earlier date as selected by the participant, subject to holding periods required by law.

Amount includes stock units acquired pursuant to a dividend equivalent feature.

This option is 100% vested.

This option vests in three annual installments (33%, 33%, and 34%) beginning on the date shown.

These restricted stock units convert into shares of common stock on a 1-for-1 basis.

These restricted stock units vest in three annual installments (33%, 33%, and 34%) beginning on the date shown.

Amount includes restricted stock units acquired pursuant to a dividend equivalent reinvestment feature.


Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Amount includes shares acquired pursuant to a dividend reinvestment plan.

This option is 100% vested.


Each depositary share represents a 1/40th interest in a share of the Issuer's 6.75% Fixed-Rate Non-Cumulative Perpetual Preferred Stock, Series B, no par value per share. Depositary shares purchased in an underwritten public offering.


This transaction was executed in multiple trades at prices ranging from $133.38 to $133.48. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Jeffrey S. McFall as attorney-in-fact for Zackery A. Hicks


Common Stock

Common Stock

Common Stock

Common Stock

These shares were retained by the Company in order to meet the tax withholding obligations of the Reporting Person in connection with the vesting of the restricted stock unit award. The Compensation and Organizational Development Committee approved the disposition of shares by the Reporting Person and the amount retained by the Company was not in excess of the amount of the tax liability.

In accordance with the employment agreement of the Reporting Person and the subsequent separation agreement entered into between the Reporting Person and the Company, all outstanding and unvested restricted stock units held by the Reporting Person were accelerated and vested in connection with the termination of employment of the Reporting Person.

By: POA pursuant Liz Ramirez For: Ajei Gopal


Common Stock

The stock units convert to ConocoPhillips common stock on a 1-for-1 basis.

The reporting person has elected to receive payment as a lump sum six months following separation from service, which election may be changed by the reporting person to provide for an alternative schedule of deferred payments.

Includes dividend equivalent units acquired through routine transactions that are exempt under rule 16a-11.

Whitney A. Cox, Attorney in Fact (by Power of Attorney filed with the Commission on September 4, 2024)


Common Stock

The reporting person has elected to receive payment in five equal annual installments beginning one year following separation from service, which election may be changed by the reporting person to provide for an alternative schedule of deferred payments.

Includes units acquired through routine dividend transactions that are exempt under rule 16a-11.

Whitney A. Cox, Attorney in Fact (by Power of Attorney filed with the Commission on March 4, 2024)


The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.6700 to $142.6400, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.6700 to $143.6660, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.6700 to $144.6300, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

As of July 31, 2025, the reporting person had a balance of $193,678.01 in the Nucor Stock Fund in the Nucor Profit Sharing Plan. The number of shares has been calculated by the plan administrator of such plan.

/s/ Caitlin A. Kelly, attorney-in-fact for Mr. Topalian


Kristina Benson Power of Attorney on behalf of Joseph R. Trpik Jr.


Common Stock

Includes 7,348 unvested Restricted Stock Awards.

Pursuant to a "net exercise" of outstanding stock options, the Issuer withheld a portion of the shares of common stock to be acquired upon exercise for payment of the exercise price and tax withholdings.

This grant becomes exercisable in three equal annual installments beginning on the date shown above.

By Victoria Pool, Power of Attorney for Carolyn J. Monroe


/s/ Caitlin A. Kelly, attorney-in-fact for Mr. Behr


/s/Katherine L. Karel, Attorney-In-Fact for Joan Budden


Common Stock

Stock options subject to the Optionee's continuous service as a director through such date, twenty-five percent of the Shares on each of August 31, 2020, November 30, 2020, February 28, 2021 and May 31, 2021.


The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 27, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.89 to $5.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

/s/ Vanina de Verneuil, Attorney-In-Fact


The reporting person is reporting the withholding of 881 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of time-based restricted stock.

The reporting person is reporting the withholding of 3,892 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of performance-based stock.


/s/ Christy Lombardi, Attorney in Fact for Michael Brian Adams


Common Stock

Represents the weighted average of a range of sale prices from $88.50 to $88.51. The reporting person undertakes to provide to the Staff of the Securities and Exchange Commission, the Company, or any stockholder of the Company, upon request, full information regarding the number of shares sold at each separate price.

Received as employment compensation

/s/ Michael Peterson by Diane Gallagher, attorney-in-fact


Invesco Commercial Real Estate Finance Trust, Inc.

Represents the acquisition by Invesco Advisers, Inc. (the issuer's adviser) of Class E Common Stock as payment of its management fee. The Reporting Persons are directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.


Represents the repurchase of shares of Class E Common Stock held by Invesco Advisers, Inc. (IAI), which is a wholly owned indirect subsidiary of Invesco Ltd., the ultimate parent entity. The Reporting Persons are directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.

Represents the acquisition by IAI of Class E Common Stock as payment of its management fee.


NYLI CBRE Global Infrastructure Megatrends Term Fund


This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2024.

/s/ M. Kathryn Rickards, attorney-in-fact


The price reported is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $56.95 to $57.30 inclusive.

By: Power of Attorney For: /s/ Nancy E. Cooper


566 of these shares are deferred shares deposited in the director's deferred account, which will be automatically distributed in predetermined installments after the director ceases being a director of the Company.

Beneficial holdings include 153 shares acquired pursuant to dividend reinvestment in June 2025.

By: Power of Attorney For: /s/ Joseph W. McClanathan


Deferred shares deposited in the director's deferred account, which will be automatically distributed in predetermined installments after the director ceases being a director of the Company.

Beneficial holdings include 65 shares acquired pursuant to dividend reinvestment in June 2025.

By: Power of Attorney: /s/MaryAnn Wright


Barbara B Singer 2014 Irrevocable  Trust

Beneficial holdings include 188 shares acquired pursuant to dividend reinvestment in June 2025.

By: Power of Attorney For: /s/ David V. Singer


Beneficial holdings include 268 shares acquired pursuant to dividend reinvestments in June 2025.

By: Power of Attorney For: /s/ David C. Everitt


Beneficial holdings include 114 shares acquired pursuant to dividend reinvestments in June 2025.

By: Power of Attorney For: /s/ Lauren Patricia Flaherty


By: Power of Attorney for : /s/ Reginald Fils-Aime


Beneficial holdings include 660 shares acquired pursuant to dividend reinvestments in June 2025.

By: Power of Attorney For: /s/ J. Steven Whisler


Beneficial holdings include 489 shares acquired pursuant to dividend reinvestments in June 2025.

By: Power of Attorney For: /s/ Roger J. Wood


Jennifer Desroches - By POA Wayne Lamberton, Director


Carol Samaan, SVP, Legal (Attorney-In-Fact)


This figure does not include 99,614 shares held directly by Mr. Stahl.

For each indirect account, Mr. Stahl disclaims beneficial ownership except to the extent of his pecuniary interest, if any.


Third quarter stock grant for 2025 received pursuant to the NorthWestern Energy Group, Inc. compensation rate schedule for non-employee directors.

Represents underlying deferred share units that are issuable subsequent to the reporting person's termination of service from the company.

Grant price as of June 30, 2025. Shares issued as deferred share units on August 1, 2025.

Includes shares acquired from dividend reinvestment.


By the Alerus Financial Corporation Employee Stock Ownership Plan

Reflects ESOP allocations that have occurred since the date of the reporting person's last ownership report.

/s/ Nicholas Brenckman, by power of attorney


William E. Matthews, V, CFO, pursuant to power of attorney


On December 18, 2024, Horizon Kinetics Asset Management LLC (HKAM) filed an amendment to its Schedule 13D, in which it noted beneficial ownership of 3,578,173 shares and Murray Stahl's direct interest in 7,848 shares and his indirect interest in approximately 156,083 shares. The extent of HKAM's pecuniary interest in the shares beneficially owned is disclosed herein. Mr. Stahl does not exercise investment discretion with respect to the securities of the Issuer.


By: Annette L. Burns, Power of Attorney For: John H. Watt, Jr.


Common Stock

Each unit represents one phantom share of common stock.

These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

/s/ Shanice A. Reid, by power of atty., for Albert Bourla


Reflects a grant of time-based RSUs that vests in equal annual installments on the first three anniversaries of the grant date.


BLACKROCK CALIFORNIA MUNICIPAL INCOME TRUST


On August 1, 2025 the Company awarded 2,875 restricted share units under the Company's stock plan. The units vest in three equal annual installments beginning on August 1, 2026, unless, with certain exceptions, the reporting person ceases to be an employee prior to the vesting date.

Jennifer L. McDonough on behalf of Joseph M. Rutledge


Common Stock

Represents a net exercise of outstanding stock options.  The reporting person received 92,654 shares of common stock on the net exercise of option to purchase 120,313 shares of common stock.  The issuer withheld 27,659 shares of common stock underlying the option for payment of the exercise price using the closing price of $1.74.


Includes 6.2025 dividend equivalent units.  Each dividend equivalent unit is the economic equivalent of one share of Selective Insurance Group, Inc. common stock.


This is not a report of transactions (no acquired/disosed securities), but an amendment made to the incorrect Form 3 filing for Mr. Nick Veronis on 7/18/2025.


Common Stock

Represents a net exercise of outstanding stock options.  The reporting person received 90,606 shares of common stock on the net exercise of option to purchase 120,313 shares of common stock.  The issuer withheld 27,659 shares of common stock underlying the option for payment of the exercise price using the closing price of $1.74.


Allocated to the reporting person's account pursuant to a dividend reinvestment feature of the CSB Bancorp, Inc. Dividend Reinvestment Plan

/s/ Stephen E. Schillig by Margaret L. Conn, Attorney-in-Fact pursuant to Power of Attorney filed herewith


The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 27, 2024.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.93 to $2.00, inclusive. The reporting person undertakes to provide to Expensify, Inc., any security holder of Expensify, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.


The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.92 to $1.97, inclusive. The reporting person undertakes to provide to Expensify, Inc., any security holder of Expensify, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

By Barrett Trust LLC, a manager-managed limited liability company. The investment and voting decisions of Barrett Trust LLC are made by its manager, the Reporting Person, and its controlling member is the Barrett Family Trust, for which the Reporting Person serves as trustee.